Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Cardiovascular diseases (CVDs) are the leading cause of death globally<sup>1</sup>

Cardiovascular diseases (CVDs) are the leading cause of death globally1

According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.

A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.

Flu and Vaccination

Flu and Vaccination

Flu and Diabetes

Flu and Diabetes

Flu and Respiratory Disease

Flu and Respiratory Disease

Flu and Cardiovascular Disease

Flu and Cardiovascular Disease

Legacy Video for Rare Disease Academy

Legacy Video for Rare Disease Academy

Learning aRMMs

Learning aRMMs

Groundbreaking SoliD Study: Comparative Efficacy of iGlarLixi and IDegAsp

Groundbreaking SoliD Study: Comparative Efficacy of iGlarLixi and IDegAsp

Lipid Management in Patients with Diabetes Mellitus

Lipid Management in Patients with Diabetes Mellitus

SoliD: Redefine Treatment Paradigm Post-OAD

SoliD: Redefine Treatment Paradigm Post-OAD